We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
-3.73%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$7.08B
AUM Growth
-$434M
Cap. Flow
+$37.4M
Cap. Flow %
0.53%
Top 10 Hldgs %
21.37%
Holding
240
New
5
Increased
85
Reduced
123
Closed
13

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$70.1M
2
BUD icon
AB InBev
BUD
+$16M
3
GE icon
GE Aerospace
GE
+$15.8M
4
CMCSA icon
Comcast
CMCSA
+$13M
5
LW icon
Lamb Weston
LW
+$12.6M

Sector Composition

Rank Sector Weight
1 Financials 19.81%
2 Technology 17.12%
3 Healthcare 14.64%
4 Communication Services 8.71%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIN icon
126
Fortune Brands Innovations
FBIN
$6.06B
$3.41M 0.05%
53,676
-39,740
-43% -$3.06M
DISCK
127
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$3.36M 0.05%
134,485
+5,075
+4% +$138K
INTC icon
128
Intel
INTC
$513B
$3.29M 0.05%
66,403
-16,748
-20% -$830K
ZION icon
129
Zions Bancorporation
ZION
$10.3B
$2.79M 0.04%
42,572
-5,075
-11% -$347K
XOM icon
130
ExxonMobil
XOM
$634B
$2.77M 0.04%
33,509
-1
-0% -$78
PFE icon
131
Pfizer
PFE
$153B
$2.32M 0.03%
44,892
+537
+1% +$27.9K
SCS
132
DELISTED
Steelcase
SCS
$2.27M 0.03%
+190,268
New +$2.3M
FDX icon
133
FedEx
FDX
$75.4B
$2.27M 0.03%
9,825
-82
-0.8% -$19.3K
ABBV icon
134
AbbVie
ABBV
$435B
$2.22M 0.03%
13,686
-216
-2% -$31.4K
ZTS icon
135
Zoetis
ZTS
$30B
$2.01M 0.03%
10,656
-5,773
-35% -$1.14M
ADBE icon
136
Adobe
ADBE
$105B
$1.99M 0.03%
4,365
-55
-1% -$26.5K
ABT icon
137
Abbott
ABT
$187B
$1.93M 0.03%
16,331
-1,228
-7% -$152K
VZ icon
138
Verizon
VZ
$196B
$1.88M 0.03%
36,962
+1,363
+4% +$72.2K
CL icon
139
Colgate-Palmolive
CL
$74.4B
$1.85M 0.03%
24,442
-1,875
-7% -$149K
ADP icon
140
Automatic Data Processing
ADP
$108B
$1.81M 0.03%
7,976
-366
-4% -$78.4K
LAMR icon
141
Lamar Advertising Co
LAMR
$16.3B
$1.79M 0.03%
15,390
-1,900
-11% -$212K
VRSK icon
142
Verisk Analytics
VRSK
$25B
$1.73M 0.02%
8,037
-4,725
-37% -$932K
APD icon
143
Air Products & Chemicals
APD
$67.6B
$1.68M 0.02%
6,713
-542
-7% -$139K
SBUX icon
144
Starbucks
SBUX
$120B
$1.56M 0.02%
17,170
-2,642
-13% -$249K
BBWI icon
145
Bath & Body Works
BBWI
$4.1B
$1.54M 0.02%
32,145
-9,970
-24% -$538K
CAT icon
146
Caterpillar
CAT
$387B
$1.5M 0.02%
6,750
+1
+0% +$210
WMT icon
147
Walmart Inc
WMT
$890B
$1.47M 0.02%
29,673
-891
-3% -$41.8K
MMM icon
148
3M
MMM
$94.3B
$1.08M 0.02%
8,642
-902
-9% -$120K
MKC icon
149
McCormick & Company Non-Voting
MKC
$14.2B
$1.07M 0.02%
10,687
-1,011
-9% -$98.8K
ZIMV
150
DELISTED
ZimVie
ZIMV
$1.03M 0.01%
+45,331
New +$1.07M

Similar funds

Douglas Lane & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Douglas Lane & Associates held 240 positions worth $7.08B, down 5.8% from $7.52B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas Lane & Associates's Q1 2022 filing shows 5 new, 85 increased, 123 reduced and 13 closed positions. Its largest new stake was Shell: 1,320,198 shares worth $72.5M. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $56.5M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q1 2022 buy was Shell: 1,320,198 shares worth $72.5M.
  • Douglas Lane & Associates added most to AB InBev in Q1 2022, an estimated $16M increase.
  • Douglas Lane & Associates's biggest Q1 2022 reduction was APA Corp, cutting an estimated $14.4M.
  • Douglas Lane & Associates fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $56.5M.
  • Douglas Lane & Associates's ten largest holdings make up 21% of its $7.08B portfolio in Q1 2022.
  • Douglas Lane & Associates opened 5 new positions and closed 13 in Q1 2022.
  • Douglas Lane & Associates's portfolio value fell 5.8% quarter-over-quarter to $7.08B.

Based on Douglas Lane & Associates's 13F filing for Q1 2022, filed 25 Apr 2022.